{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:04:37Z","timestamp":1769555077906,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Alkermes, Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jsat.2015.07.005","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T06:14:27Z","timestamp":1437200067000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["A Phase 4, Pilot, Open-Label Study of VIVITROL\u00ae (Extended-Release Naltrexone XR-NTX) for Prisoners"],"prefix":"10.1016","volume":"59","author":[{"given":"Michael S.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy W.","family":"Kinlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Vocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence T.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli","family":"Memisoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsat.2015.07.005_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijlp.2011.07.002","article-title":"From the prison door right to the sidewalk, everything went downhill. A qualitative study of the health experiences of recently released inmates","volume":"34","author":"Binswanger","year":"2011","journal-title":"International Journal of Law and Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2014A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1360-0443.2003.00264.x","article-title":"Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996\u201399","volume":"98","author":"Bird","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2015.07.005_bb9000","series-title":"Contemporary Drug Policy","author":"Brownstein","year":"2013"},{"key":"10.1016\/j.jsat.2015.07.005_bb9005","series-title":"Prisoners in 2012: Advance counts","author":"Carson","year":"2013"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb8000","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2008.976","article-title":"Treating drug abuse and addiction in the criminal justice system: improving public health and safety","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2015.07.005_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08897077.2011.609438","article-title":"A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers","volume":"33","author":"Coviello","year":"2012","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb9010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cct.2014.09.002","article-title":"Design and methods of a double blind randomized placebo-controlled trial of extened-release naltrexone for HIV-infected opioid dependent prisoners and jail detainees who are transitioning to community","volume":"39","author":"Di Paola","year":"2014","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.jsat.2015.07.005_bb0040","series-title":"Prison and drugs: A global review of incarceration, drug use, and drug services","author":"Dolan","year":"2007"},{"key":"10.1016\/j.jsat.2015.07.005_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0376-8716(03)00187-X","article-title":"A randomized controlled trial of methadone maintenance treatment versus wait list control in an Australian Prison System","volume":"72","author":"Dolan","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"25","key":"10.1016\/j.jsat.2015.07.005_bb0045","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","article-title":"Methadone treatment of randomly selected criminal addicts","volume":"280","author":"Dole","year":"1969","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1360-0443.2007.02081.x","article-title":"Acute risk of drug-related death among newly released prisoners in England and Wales","volume":"103","author":"Farrell","year":"2008","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: A systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2015.07.005_bb9015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-Assisted treatment in the criminal justice drug abuse treatment studies (CJ-DATS 2): Availability, need, barriers and readiness","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2015.07.005_bb9020","article-title":"Durability of effect of long-acting injectable naltrexone","author":"Gastfriend","year":"2005","journal-title":"American Psychiatric Association Institute"},{"key":"10.1016\/j.jsat.2015.07.005_bb0060","series-title":"Presented as part of a symposium: Incarceration and opioid dependence: Impact, interventions, and implications. Addiction Health Services Research Conference. Boston, MA","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Findings at 12-months post release","author":"Gordon","year":"2008"},{"key":"10.1016\/j.jsat.2015.07.005_bb9025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug and Alcohol Dependence, Sep. 1"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb9030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08897077.2014.902787","article-title":"Buprenorphine treatment for probationers and parolees","volume":"36","author":"Gordon","year":"2015","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.jsat.2015.07.005_bb9035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"Hedrich","year":"2012","journal-title":"Addiction"},{"issue":"8\u201310","key":"10.1016\/j.jsat.2015.07.005_bb0065","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1081\/JA-120004162","article-title":"Drug user treatment within a criminal justice context","volume":"37","author":"Hough","year":"2002","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.jsat.2015.07.005_bb0070","series-title":"The war on drugs IV","author":"Inciardi","year":"2008"},{"issue":"3","key":"10.1016\/j.jsat.2015.07.005_bb0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/YCO.0b013e3282fc985c","article-title":"Drug use and health among prison inmates","volume":"21","author":"Kanato","year":"2008","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.jsat.2015.07.005_bb0085","series-title":"Opioid substitution treatment in custodial settings. A practical guide","author":"Kastelic","year":"2008"},{"key":"10.1016\/j.jsat.2015.07.005_bb0095","series-title":"Lowinson & Ruiz\u2019s substance abuse: A comprehensive textbook","article-title":"Incarcerated populations","author":"Kinlock","year":"2011"},{"issue":"3","key":"10.1016\/j.jsat.2015.07.005_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months post-release","volume":"37","author":"Kinlock","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2015.07.005_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0093854807309111","article-title":"A Study of methadone maintenance for male prisoners: 3-Month post-release outcomes","volume":"35","author":"Kinlock","year":"2008","journal-title":"Criminal Justice Behavior"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2015.07.005_bb0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release","volume":"91","author":"Kinlock","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2015.07.005_bb0100","series-title":"Heroin addiction: Prevalence, treatment approaches and health consequences","first-page":"127","article-title":"Pharmacotherapy for incarcerated individuals with histories of heroin addiction","author":"Kinlock","year":"2015"},{"key":"10.1016\/j.jsat.2015.07.005_bb0120","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/002204260303300406","article-title":"Prediction of the criminal activity of incarcerated drug-abusing offenders","volume":"33","author":"Kinlock","year":"2003","journal-title":"Journal of Drug Issues"},{"issue":"1","key":"10.1016\/j.jsat.2015.07.005_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/PAF.0b013e3181873784","article-title":"Drugs, detention, and death: A study of the mortality of recently released prisoners","volume":"30","author":"Krinsky","year":"2009","journal-title":"American Journal of Forensic Medicine and Pathology"},{"issue":"5","key":"10.1016\/j.jsat.2015.07.005_bb9040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11920-010-0135-5","article-title":"Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available","volume":"12","author":"Krupitsky","year":"2010","journal-title":"Current psychiatry reports"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb9045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugpo.2012.07.007","article-title":"Injection drug users' and their risk networks' experiences of and attitudes towards drug dealer violence in Baltimore, Maryland","volume":"24","author":"Latkin","year":"2013","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2015.07.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized effectiveness trial","author":"Lee","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2015.07.005_bb0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cct.2015.01.005","article-title":"Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: Rationale and design of a randomized controlled effectiveness trial","volume":"41","author":"Lee","year":"2015","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.jsat.2015.07.005_bb0140","series-title":"Extended-release naltrexone for opioid relapse prevention among community CJS participants","author":"Lee","year":"2015"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2015.07.005_bb0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2015.07.005_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/002204269302300106","article-title":"The effectiveness of in-jail methadone maintenance","volume":"23","author":"Magura","year":"1993","journal-title":"Journal of Drug Issues"},{"issue":"3","key":"10.1016\/j.jsat.2015.07.005_bb8005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"10.1016\/j.jsat.2015.07.005_bb0155","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2015.07.005_bb0160","first-page":"5","article-title":"Evaluation of opioid-dependent prisoners in oral opioid maintenance therapy","volume":"12","author":"Metz","year":"2010","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"10.1016\/j.jsat.2015.07.005_bb0170","series-title":"Drug use and dependence, state and federal prisoners, 2004","author":"Mumola","year":"2006"},{"key":"10.1016\/j.jsat.2015.07.005_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2015.07.005_bb0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bsl.2370090303","article-title":"Recent research on the relationship between illicit drug use and crime","volume":"9","author":"Nurco","year":"1991","journal-title":"Behavioral Sciences and the Law"},{"issue":"3","key":"10.1016\/j.jsat.2015.07.005_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jurban\/jti072","article-title":"Attitudes and practices regarding the use of methadone in US state and federal prisons","volume":"82","author":"Rich","year":"2005","journal-title":"Journal of Urban Health"},{"issue":"1","key":"10.1016\/j.jsat.2015.07.005_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1467-842X.2004.tb00629.x","article-title":"Risk of death in prisoners after release from jail","volume":"28","author":"Stewart","year":"2004","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"10.1016\/j.jsat.2015.07.005_bb9050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-7-17","article-title":"Drug use and opioid substitution treatment for prisoners","volume":"7","author":"Stover","year":"2010","journal-title":"Harm Reduction Journal"},{"issue":"8","key":"10.1016\/j.jsat.2015.07.005_bb0200","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1360-0443.2006.01475.x","article-title":"Persistence of drug use during imprisonment: Relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison","volume":"101","author":"Strang","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2015.07.005_bb0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsat.2006.12.019","article-title":"Drug treatment services for adult offenders: The state of the state","volume":"32","author":"Taxman","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2015.07.005_bb9055","first-page":"14","article-title":"The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates","volume":"68","author":"Tomasino","year":"2001","journal-title":"The Mount Sinai Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2015.07.005_bb9060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"Journal of addictive diseases"},{"issue":"2","key":"10.1016\/j.jsat.2015.07.005_bb9065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","volume":"45","author":"Zaller","year":"2013","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:43:02Z","timestamp":1760038982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547215001750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":51,"alternative-id":["S0740547215001750"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2015.07.005","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase 4, Pilot, Open-Label Study of VIVITROL\u00ae (Extended-Release Naltrexone XR-NTX) for Prisoners","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2015.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}